These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 3153792)

  • 1. Islet cell surface antibodies in Graves' disease; as organ non-specific antibodies.
    Ahn IM; Izumi M; Nagataki S
    Korean J Intern Med; 1988 Jan; 3(1):38-44. PubMed ID: 3153792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Transplacental passage of autoantibodies from a mother with diabetes and Graves' disease to her infant.
    Yamaguchi Y; Yamamoto H; Nakanishi T; Chikuba N; Akazawa S; Nagataki S
    Jpn J Med; 1990; 29(1):71-6. PubMed ID: 2214351
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pancreatic islet cell and thyroid antibodies, and islet cell function in diabetic patients of Mexican-American origin.
    Zeidler A; Frasier SD; Penny R; Stein RB; Nicoloff JT
    J Clin Endocrinol Metab; 1982 May; 54(5):949-54. PubMed ID: 7037824
    [No Abstract]   [Full Text] [Related]  

  • 4. Prevalence & significance of pancreatic islet cell & adrenal antibodies in patients with Graves' disease.
    Goswami R; Srikanta SS; Kochupillai N
    Indian J Med Res; 1995 May; 101():201-6. PubMed ID: 7601498
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Absence of islet cell autoantibodies in Jamaican blacks with diabetes mellitus.
    Morrison EY; Rosenbloom AL; McLaren NK; Riley WJ; Kooperman S
    West Indian Med J; 1986 Mar; 35(1):35-7. PubMed ID: 3521093
    [No Abstract]   [Full Text] [Related]  

  • 6. Abnormal B lymphocyte function in thyroid glands from patients with Graves' disease.
    Ueki Y; Eguchi K; Otsubo T; Kawabe Y; Shimomura C; Tezuka H; Nakao H; Kawakami A; Migita K; Ishikawa
    J Clin Endocrinol Metab; 1989 Nov; 69(5):939-45. PubMed ID: 2793996
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combined analysis of GAD65 and ICA512(IA-2) autoantibodies in organ and non-organ-specific autoimmune diseases confers high specificity for insulin-dependent diabetes mellitus.
    Pietropaolo M; Peakman M; Pietropaolo SL; Zanone MM; Foley TP; Becker DJ; Trucco M
    J Autoimmun; 1998 Feb; 11(1):1-10. PubMed ID: 9480718
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence that type I diabetes and thyrogastric autoimmunity have different genetic determinants.
    Gorsuch AN; Dean BM; Bottazzo GF; Lister J; Cudworth AG
    Br Med J; 1980 Jan; 280(6208):145-7. PubMed ID: 6766770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interaction of lymphocytes and thyrocytes in Graves' disease and nonautoimmune thyroid diseases in immunohistochemical and ultrastructural investigations.
    Ben-Skowronek I; Sierocinska-Sawa J; Szewczyk L; Korobowicz E
    Horm Res; 2009; 71(6):350-8. PubMed ID: 19506393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Thyrotropin binding inhibiting antibody (TBIAb) in Graves' disease.
    Cho WY; Choi HH; Chun HJ; Ahn IM
    Korean J Intern Med; 1988 Jan; 3(1):45-51. PubMed ID: 2908684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graves' disease of the beta cell: glucose dysregulation due to islet-cell stimulating antibodies.
    Wilkin TJ; Hammonds P; Mirza I; Bone AJ; Webster K
    Lancet; 1988 Nov; 2(8621):1155-8. PubMed ID: 2903375
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Islet cell antibodies in patients with autoimmune thyroid disease.
    Yamaguchi Y; Chikuba N; Ueda Y; Yamamoto H; Yamasaki H; Nakanishi T; Akazawa S; Nagataki S
    Diabetes; 1991 Mar; 40(3):319-22. PubMed ID: 1999272
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Small intestinal functions in Graves' disease with special reference to thyroid antibodies.
    Rao PS; Gupta PS; Rao B; Ghosh BK; Prakash P; Misra RC
    Indian J Med Res; 1981 Jan; 73():96-100. PubMed ID: 6894585
    [No Abstract]   [Full Text] [Related]  

  • 14. Thyroid-stimulating and eye muscle antibodies in Graves' disease and Graves' orbitopathy.
    Kahaly G; Grübl M; Moncayo R; Schilling S; Weber P; Beyer J; Krause U
    Dev Ophthalmol; 1989; 20():68-78. PubMed ID: 2574117
    [No Abstract]   [Full Text] [Related]  

  • 15. Islet cell and glutamic acid decarboxylase antibodies in hyperthyroid patients: at diagnosis and following treatment.
    Hallengren B; Falorni A; Landin-Olsson M; Lernmark A; Papadopoulos KI; Sundkvist G
    J Intern Med; 1996 Jan; 239(1):63-8. PubMed ID: 8551202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Study of thyroid autoimmunity in man. Contribution of cell cultures to the study of antibodies stimulating the thyroid gland in Basedow's disease].
    Yeni P; Pautard B; Charreire J
    Presse Med; 1983 Oct; 12(38):2383-7. PubMed ID: 6314325
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Islet cell antibodies in diabetic patients with other autoimmune diseases (author's transl)].
    Pujol-Borrell R; Richart C; Marti S; Gomez JM
    Nouv Presse Med; 1981 Sep; 10(34):2791-3. PubMed ID: 7031598
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies.
    Bottazzo GF; Florin-Christensen A; Doniach D
    Lancet; 1974 Nov; 2(7892):1279-83. PubMed ID: 4139522
    [No Abstract]   [Full Text] [Related]  

  • 19. Organ-specific autoantibodies in Chinese patients newly diagnosed with type 1 diabetes mellitus.
    Pan S; Wu T; Shi X; Xie Z; Huang G; Zhou Z
    Endocr J; 2020 Jul; 67(7):793-802. PubMed ID: 32295990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The human major histocompatibility complex and endocrine disease.
    Farid NR; Bear JC
    Endocr Rev; 1981; 2(1):50-86. PubMed ID: 7028471
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.